Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Trusted Voices
Together We Can Change the Odds for People with Cancer
One in three people in the United States will receive a cancer diagnosis in their lifetime.i This means you, or someone you know, may someday be impacted. This disease does not discriminate. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support. To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing...
Trusted Voices
Bringing Together Diverse Organizations to Strive for Health Equity
As a Black woman who grew up living in subsidized housing in the U.S., I know what it means to live in a world where healthcare is not equal, and not trusted. Like so many others, I have family and friends along the health spectrum who have little interest in going to the doctor because they don’t feel seen or heard. This well-earned lack of trust has led some to decide against receiving the COVID-19 vaccine, among other healthcare services and interventions. I know firsthand the work that...
Trusted Voices
Why Compliance Matters and Why Patients Should Care
In 2020, as pharmaceutical companies raced to develop a vaccine in record time, the public got a rare and exciting glimpse into an area of science that’s not usually in the spotlight: drug development. Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that would change the course of the pandemic. Along the way, those who watched learned a lot about the technical processes involved in creating...
Trusted Voices
Thanking Rod MacKenzie for his countless contributions to Pfizer
Thanking Rod MacKenzie for his countless contributions to Pfizer, the industry and patients around the globe. After 35 years of outstanding service to Pfizer, Rod MacKenzie, PhD, Chief Development Officer and Executive Vice President, has informed me of his intent to retire early next year. This is a bittersweet time for me and for all those colleagues who have worked with Rod over the course of his career. I will miss working with my friend, but I am excited to see the wonderful things he...
Trusted Voices
Thanking John Young for His Years of Service to Pfizer – and to Patients
It is with mixed emotions that I share the news that John Young, Pfizer’s Chief Business Officer, will retire in early 2022, following a distinguished 34-year career at Pfizer. John’s list of significant accomplishments at Pfizer is long, but perhaps none is more important than his essential role in cultivating the collaborations that led to the successful development and delivery of the Pfizer-BioNTech COVID-19 vaccine. During his time at Pfizer, John has led many large-scale transformations...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.